The COVID vaccines have sharply reduced mortality rates from the pandemic across the board. Pfizer has projected annual sales of its vaccine at $34 billion and Moderna at $18 billion to $19 billion. The price increases reflect what Moderna and Pfizer both refer to as the transition to commercial marketing of the vaccines. The government arguably has authority over pricing and distribution of products developed with federal funding, such as the COVID vaccines. The COVID vaccines could be another test case.

Source: Los Angeles Times January 25, 2023 02:07 UTC